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ABSTRACT

Antibodies are proteins of the immune system that exhibit exquisite specificity to their binding
partners, called antigens. Binding occurs at the hypervariable region (Fv), which is capable of
discriminating even enantiomeric molecules. By targeting on the DNA sequences that code for Fv
and expressing it as a protein, the binding properties of an antibody can be assessed. In this
project, the heavy and light chains of the Fv region (Vh and V[_) of an anti-amino acid antibody
(anti-phenylalanine 67.36) were linked using a short nucleotide linker and four primers designed
from previously determined sequences of Vh and V|_. The resulting V|-H¡nker-V|_(HIL) construct - a
single chain variable fragment (67.36 HIL scFv) - was inserted into a TOPO cloning vector and
transformed into E. coli BL 21 expression cells. 1 L cultures were grown at 37°, 30° and 27 °C.
Cells were collected, resuspended and lysed to release the protein of interest. Isolation and
purification was performed using a metal (cobalt) affinity chromatography resin. Characterization by
SDS-PAGE indicated a correlation between incubation temperature and extent of expression.
Noncompetitive ELISA tests revealed a functional 67.36 HIL scFv. However, further tests e.g.,
competitive ELISA, must be carried out to confirm an enantiomeric preference.

INTRODUCTION

I. Chirality
Chirality is the structural characteristic that makes it
impossible to superimpose a molecule with its mirror image.
The most common form of chirality occurs in molecules that
possess an asymmetric center. The two mirror images, called
enantiomers, are identical in atomic constitution and bonding,
but differ in the three-dimensional arrangement of its
substituents. Such molecules have essentially the same physical properties, but may show
different behavior in a chiral environment (e.g., the human body). Most biological molecules are
chiral and all organisms on Earth and their numerous physiological processes are stereoselective,
utilizing, e.g., amino acids and sugars in only one of the two possible mirror-image forms. Important
biological macromolecules that are stereoselective are enzymes, receptors, and antibodies.

II. The Antibody
Antibodies are proteins produced by B-cells to combat the numerous foreign invaders our
immune system encounters on a daily basis. The basic four-chain structure of antibodies is shown
in figure 1. Generally Y-shaped, it is comprised of two identical light and heavy chains. Antigen
recognition and interaction occurs in the antigen-binding site located at the ends of the “arms” of
the molecule.
There are generally five different classes of antibodies in existence: IgA, IgD, IgE, IgG, and
IgM. The general four-chain structure is common for all
monomeric

immunoglobulin

molecules.

Polymeric

immunoglobulins of higher molecular weights are formed by
2-6 four-chain subunits. Therefore they differ not only in their
physiological roles but also in their overall structures. For
example, IgA is a dimer comprised of two Y-shaped antibody
subunits. In this research project, 67.36, a type of IgG
antibody, was studied and observed.
Figure 1. General Structure of Antibodies

II. A Closer Look - Structural Basis for Specificity
Form a structural point of view (figure 2), IgG antibodies are a particular class of
immunoglobulins that have been extensively studied because of the dominant role they play in a
mature immune response.
The IgG molecule can be broken down into two
regions: Fc and Fab. Each immunoglobulin light (L)
or heavy (H) chain is structurally segmented into
domains that are either of the variable type (Vl and
Vh) or the constant type (CHi, CH2, or CH3). The

Fab region contains the antigen-binding site, which
is comprised of the hypervariable Fv region (V l +
Vh). It is important to note that this area of highly

variable amino acids are confined to 6 protein loops
Figure 2. IgG Structure

that cluster together at the end of the Fab fragments to form a continuous hypervariable surface. It
is this region that is responsible for antibody specificity and is the area of focus for this research
project.
The specificity of antibodies is incredible, able to differentiate between enantiomers. As
mentioned earlier, enantiomers are molecules that are optical isomers, or mirror images, of one
another. These non-superimposable molecules can be distinguished by the direction in which they
rotate the plane of polarization of polarized light and are referred to, therefore, as being
dextrorotatory (D-type or right handed) or laevorotatory (L-type or left handed).
Since antibodies can be raised against virtually any compound, practical applications of
antibody stereoselectivity is currently being researched; this can range from the detection of
enantiomeric impurity in drugs to the chromatographic separation of enantiomeric mixtures.

III. Importance and Goals of this Project
All organisms on Earth use amino acids and sugars in only one of the two possible mirrorimage forms. Since enantiomers are essentially the same molecule, possessing the same
molecular weight and physical properties, separating the two forms is not only difficult but also
time-consuming. This makes it challenging to separate racemic samples, which contain both forms.
This is especially relevant in drugs manufactured for human consumption because minor
enantiomeric impurities may cause sever pharmacologic and toxicologic side effects. Thus
antibody practical applications for antibody stereoselectivity can range from the detection of
enantiomeric impurity in drugs to the chromatographic separation of enantiomeric mixtures
Because of the effectiveness of antibody stereoselectivity, applications are being
developed to attain analytical techniques for the precise determination of
s c F v F ra g m e n t
linker
-peptide
Vh

J

.

biorelevant chrial molecules.

Currently there are several analytical

techniques used for separating
My research project focuses on the production of a scFv
fragment from the antigen-binding site (Fab) of anti-AA 67.36, an
antibody to phenylalanine, and the investigation of its binding properties

BACKGROUND INFORMATION

I. Monoclonal Antibodies
In order to perform the experiments and tests necessary to investigate antibody specificity,
one needs a constant source of a single type of antibody that are all built alike and manufactured
by a single clone of plasma cells, or monoclonal antibodies. Possible sources for monoclonal
antibodies are spleen cells. Since they are responsible for B-cell production, spleen cells contain
the genetic information that give rise to antibody production. B-cells are significant because each
carry a different membrane-bound antibody molecule on its surface. Therefore if an antigen is
introduced and binds to a particular B-cell, it stimulates this cell to divide. The result is the secretion
of large amounts of the same antibody in soluble form.
However, there are drawbacks if one intends to harvest monoclonal antibodies through this
procedure. First of all, the response of the immune system to any antigen, even the simplest, is
polyclonal. That is, the system manufactures antibodies of a great range of structures both in their
binding regions as well as in their effector regions. In addition, even if the isolation of a single
antibody-secreting cell were successful and the cell is placed in culture, it would die out after a few
generations because of the limited growth potential of ail normal somatic cells.
The solution to this problem is Hybridoma Technology where single antibody forming cells
are fused to tumor cells grown in culture, producing hybridoma cells. In this process, antibodies are
‘"raised” by injecting an animal (usually mice or rabbits) with an antigen, X for example. Repeated
injections of the same antigen at intervals of several weeks stimulates specific B-cells to secrete
large amounts of anti-X antibodies in the bloodstream. The cells that produce these antibodies are
fused with tumor cells and grown in a selective medium, HAT (hypoxanthine/aminoptherin/
thymine), which only allows hybridoma cells to grow.

The supernatant was extracted from

microcultures and screened for secretion of the desired antibody. Lastly, the cells with positive
results were subculture by limiting dilution such that each culture contains hybridomas with single
antibody specificity. Since there is an excess of these anti-X antibody-producing cells, the
likelihood of attaining the antibodies of interest is much greater. The result are cells monoclonal
antibodies can be raised by fusing single antibody forming cells to tumor cells grown in culture. The
resulting cell is called hybridoma.

II. Degenerate Primers
Once the specific hybridoma cell has been attained, it is now possible to gain access to the
genes of the cell that code for the antibody molecule. Within the cell is the mRNA for both light
chain and heavy chain production. The next step is now to purify the mRNA using QuickPrep
mRNA purification kit. Once the mRNA has been isolated, we can have the cDNA for the chains
since mRNA is not very stable and cDNA is. To focus on these hypervariable regions, degenerate
primers were used. Degenerate primers are a library of primers that allow wobbles at specific
locations.

III. Sequences for Variable Fragments Vh and Vl

C hain

Sequence

GTT CCg B M
g AG GTG CAG CTG GAG GAG TCT GGG GGA GGC H A GTG AAG CCT GGA
GGG TCC CTG AAA CTC TCC TGC GCA GCC TCT GGA TTC ACT TTC AGT AAC TAT GAC ATG TCT
TGG GTT CGC CAG ACT CCA GAG AAG AGA CTG GAG TGG GTC ACA TCT ATT AGT AGT GGT GGT
TAC ACC TAC TAT CCA GAC AGT GTG AAG GGC CGA TTC ACC ATC TCC AGA GAT AAT GTC AGG
AAC ATC CTG TAC CTG CAA ATG AGC AGT CTG AGG TCT GAA GAC ACG GCC ATG TAT TAC TGT
GCA AGA GCC CTT TAT GAC TAC ACT ACT AGC CCC TGG TTT GCT TAC TGG GGC CAA GGG ACT
CTG GTC ACT GTC TCT GCA GCC AAA ACG ACA CCC CCA TCT GTC TAT
TCC

H e avy
C hain

TGG
GAT A n GTG CTG ACC CAA ACT ACA GCA ATC ATG TCT GCA TCT CCA TGG GAA
AAG GTC ACC ATG ACC TGC AGG GCC AGC TCA AGT GTA AGT TCC AGT TAC TTG CAC TGG TAC
CAG CAG AAG TCA GGT GCC TCC CCC AAA CTC TGG A n TAT AGC ACA TCC AAC TTG GCC TCT
GGA GTC CCT GCT CGC TTC AGT GGC AGT GGG TCT GGG ACC TCT TAC TCT CTC ACA ATC AGC
AGT GTG GAG GCT GAA GAT GCC GCC ACT TAT TAC TGC CAG CAG TAC AGT GGT ACC CCG CTC
ACG H C GGT GCT GGG ACC AAG CTG GAG CTG AAG CGG GCT GAT GCT GCA CCA ACT GTA TCA
GGC

Lig h t
C hain

Methods

I. Amplifying Vh and V l via PCR
Polymerase chain reaction (PCR) is a common method of creating copies of specific
fragments of DNA. PCR rapidly amplifies a single DNA molecule into many billions of molecules. It
creates copies by mimicking how DNA is replicated in a cell, however using temperature as a
means of manipulating the structure of the double stranded DNA (dsDNA):

TABLE 1. Steps in PCIR
Temp
Step

Time

(°C)

(min)

Initial denaturation

94

1

Denaturation

94

1

Annealing

55

1

Elongation

72

2

Final Elongation

72

10

# of Cycles

1

35

1

Purpose

Separates dsDNA into two template
strands
Same as above
Anneals primers to template
Polymerase elongates primers to
create new strands from template
Finish elongation
Reform dsDNA

To amplify Vh and V l ,the following solutions were added into a small Eppendorf PCR tube:

Vh

Vl

Buffer
MgCI2
‘Primers

2 uL
2 uL
2
2
*67.36 HIL HR 0.4
*67.36 HILLR 0.4
*67.36 HILHF 0.4
*67.36 HIL LF 0.4
dNTP
0.4
0.4
Sterile H20
13.9
13.9
‘Template
*1’ stock
0.4
*4’stock
0.4
Tag polymerase______________ 02_______________________ 0.2
TOTAL VOLUME
20 ul
20 ul

After mixing well, a drop of mineral oil was added to the top of the solution to prevent
evaporation during denaturation. The samples were placed in the PCR machine and allowed to run
for 35 cycles according to the specifications on temperature and time as shown in table 1 (program
#9 in PCR). At the end of the program, the tubes were placed in -70° C freezer and the mineral oil
drop was removed from the surface; since mineral oil does not solidify, freezing is an efficient way
to remove the mineral oil from the surface without disturbing or removing any of the precious DNA
sample that remains in solid-form. Then, agarose-gel electrophoresis was utilized to assure that
amplfication was carried out and to check final molecular weight of fragments.
Electrophoresis is a way of separating out charged particles. When a sample is placed in a
semi-solid matrix or gel and exposed to an electric field, the ions or molecules migrate through the

gel in response to the field. Smaller particles travel faster and move further than larger ones. Highly
charged particles are also more responsive to the electric field.
The sugar phosphate backbone of DNA has a negative charge in neutral to basic solution.
Therefore when an electric charge is placed through the sample, it will move from the negative
(cathode) pole to the positive (anode) pole. A buffer solution In the unit stops the solution from
becoming acidic. The DNA sample was placed in a gelatinous matrix, agarose (1.2% agarose: 1.2
g/60 mL TAE buffer) and exposed to an electric field. Along with the sample, loading dye was
added to increase the density of the solution causing it to sink to the bottom of the agarose gel. In
addition, the dyes contain bromophenol blue and xylene cyanol, both negatively charged dyes that
will migrate to the positive pole as well.
Since DNA is not visible in the gel, the dyes give an indication of how fart he nucleic acids
have migrated. Once the samples have migrated to the bottom of the gel, the electric current was
stopped. The separated bands were visualized by staining the gels with ethidium bromide, which
become fluorescent under ultraviolet light. A photograph of the gel was taken as shown below
displays two distinct bands. These bands correspond with the known molecular weights of Vh and
VL:
•

Heavy Chain -408 bp
Light chain -370 bp

400 b|

II. Designing the Linker
The linker sequence is a short nucleotide chain that must connect the Vh and Vl domains
of a given Fv without perturbing contacts or interfering with domain folding. Various factors are
taken into consideration to optimize the chances of obtaining a functional fragment. The overall
length and %GC holds great significance since both directly affects the melting temperature (Tm).
The melting temperature is the temperature in which double stranded DNA can be separated into
single strands. Since the linker will be directly attached to the heavy and light chains, its melting
temperature must be relatively close to the Tm of the scFV.

The longer the length of the sequence, the more energy required to separate the strands,
thus an increased Tm. Increased %GC or percent guanine-cytosine has a similar effect. Basepairing nucleotides make up the ladder of double helix DNA. Guanine-cytosine base pairs are
stabilized by 3 hydrogen bonds, compared to 2 hydrogen bonds between adenine-thymine. The
more stabilized G-C pairing requires more energy to separate thus increasing Tm as more GC are
placed.
For the linker in creating 67.36 scFV, the linker must remain flexible, thus Gly and Ser
residues were introduced. Solubility is also important since the resulting protein samples must be
kept in solution during use and long-term storage. To enhance solubility, Lys and Glu were
incorporated. Degradation from proteases is imminent for proteins that are not in its native
environment. To prevent protease susceptibility, Pro residues were included. Lastly, the linker
sequence must be in an optimal length to reduce multi-dimer formation.

Length

Sequence
5’ AAC TTT AGT GCT ADD TTC ACC
ACT CCC GGG TTT GCC GCT ACC
GGA AGT AGA GCC 3’

Linker

54 bp

III. Designing the Primers
The steps in creating primers is similar to creating the linker, considering the length and %GC
to remain in a safe range. However with the primers, previously determined sequences of the
heavy and light chain were used to determine the exact amino acid composition. In addition:

•
•
•
•

Primers were created to incorporate the linker sequence
Proper length: approx 21-24 bases
Proper alignment with sequences; must occur in 5’ —►3’ direction.
Proper melting temp Tm =60-65 C (annealing temp =55 C)
% GC =below 50% ideal
acceptable if 50-55%

VH
3'

H

VL

linker
B

M

u am

m

m

■ ■ ■ ■ ■

4

2

1

3

3'

Primer

Sequence

Length

Tm
(°C)

%GC

1. Heavy Forward

5’ GTT CCG GAA TTC GAG GTG
CAG3’

21

59.4

57.1%

2. Heavy Reverse

5’ GGA AGA TCT ATA GAC AGA TGG
GGGTGT3’

27

60.8

48.1%

3. Light Forward

5’ TGG GAG CTC GAT ATT GTG CTG
ACC 3’

24

62.3

54.2%

4. Light Reverse

5’ GCC CTT AAG TGA TAC AGT TGG
TGC 3’

24

59.5

45.8%

IV. Creating scFV
Using polymerase chain reaction (PCR), the primers were elongated to form scFv HIL.
Since the length of the linker, Vh and V l were known (54, 370 and 408 bp, respectively), the
molecular weight of 67.36 scFv HIL could be calculated. The primers are strategically placed,
accompanied by portions of the linkers sequence in order for elongation to occur in the 5’ -> 3’
direction (see figure 5). This resulted in a single chain fragment.
To begin ligation, the following solutions were added to an eppendorf tube:

VH —

VL

Electrophoretic separation in an agarose gel revealed a band at about 800 bp, which
corresponds to 67.36 scFv HIL. The band was then isolated from the gel via Qiagen® Gel
Extraction Kit. This kit is designed to extract and purify DNA fragments from standard or low-melt
agarose gels in TAE or TBE buffer.
•

The DNA fragment was excised from the agarose gel with a clean, sharp scalpel.

•

The gel slice was weighed in a colorless tube. 3 volumes of Buffer QG was added
to 1 volume of gel.

• To dissolve the gel, it was incubated at 50 C for 10 min. After the gel slice has
been dissolved completely, the color of the mixture was checked to assure it
remained yellow. This indicates it is in the optimal pH.
• 1 gel volume of isopropanol was added to the sample and mixed thoroughly
• A QIAquick spin column is placed into a 2 mL collection tube.
• The sample was applied onto the QIAquick column to bind the DNA. The tube was
centrifuged for 1 min
•

The flow-through was discarded and 0.5 mL of Buffer QG was added to the
column and centrifuged for 1 min. This step removed all traced of agarose

•

The column was then washed by adding 0.75 mL of Buffer PE and centrifuged for
1 min. The flow through was discarded and the tube was centrifuged for an
additional 1 min

•

The QIAquick column was placed into a clean, 1.5 mL Eppendorf tube.

•

The DNA was eluted by adding 50 uL of H20 at the center of the column. The
tube was centrifuged at high speed for 1 min.

IV. Inserting scFV into TOPO Cloning Vector
At this point in the experiment, 67.36 is nothing more than a short fragment of DNA. In
order for 67.36 HIL to be expressed as a protein, it must first be inserted into a cloning vector. A
cloning vector is a plasmid DNA that allows the introduction of foreign DNA fragments. In this
experiment, we used a TOPO cloning vector.

TOPO TA Cloning provides a highly efficient, 5-minute, one-step cloning strategy for the
direct insertionof Taqpolymerase-amplified PCR products into a plasmid vector. Taq polymerase
has a nontemplate-dependent terminal transferase activity that adds a single deoxyadenosine (A)
to the 3’ ends of PCR products. The linearized vector has a single, overhanging 3’ deoxythymidine
Topoisomerase

(T) residues. This allows PCR insert to ligate efficiently with
the vector.

Tyr-274

(V

67.36

1L

CCCTT

J aggg

gggaI

TTCCC

JS

scFV HIL was dir

cloning vector and transformed into TOP 10 cloning cells.
First, 400 ng of the DNA fragment was added with 1 uL Dilute
Salt Solution and 1 uL TOPO vector. Water was added to

Tyr-274

bring up the total volume to 6 uL. The solution was incubated
Topoisomerase

for 5 minutes at room temperature. Then it was transformed

into TOP10 cells usingelectroporation. 250 uL of SOC medium was added and the solution was
allowed toincubate for 1 hr at 37 °C in order for cells to recover. 250 uL of the solution was plated
on agar medium and incubated overnight at 37 °C. Each resulting colony was analyzed by PCR in
order to determine if the insertion was successful. The agarose gel photograph displays colonies
that contained the insert. Only plasmids of positive colonies were isolated and transformed into £
coli BL 21 expression cells.

Buffer
MgCI2
‘Primers

2 uL
2
*67.36 HIL LR 0.4
T7
0.4
dNTP
0.4
14.6
Sterile H20
‘Template
‘Cells
Varies
0.2
Tag polymerase
TOTAL VOLUME
20 uL per colony

1000 b(

VI. Expression of Protein
Once positive colonies were identified, a DNA purification kit (Promega Wizard® Plus
Midipreps) was used to remove and isolate plasmids with the 67.36 HIL scFv insertions from cells.
Plasmids were then transformed into ampicillin resistant £ coli BL 21 expression cells by
electroporation. Transformed expression cells were placed in TB broth containing 1mL/mL

ampicillin, 0.17 M KH2PO4, and 0.72 M K2HPO4.1L cultures were incubated at 37°, 30° and 27°
C. After a 24-hour incubation period, cells were induced with IPTG. 1.5 hours after induction, cells
were collected by centrifugation at 5,000 x g. The supernatant was discarded and the cell pellet
was frozen overnight at -20° C.

VII. Isolation and Purification of protein
Prior to cell lysis, cells were thawed on ice. 3 mL of extraction/wash buffer (50 mM
NaH2P04, 300 mM NaCI) per 1 g of cells were added to resuspend the pellet. DNAse was then
added (100 - 300 mL) to decrease the viscosity of the solution and allow more efficient cell lysis.
Cells were lysed in a French Press at 2000 psi. The resulting solution was collected and
centrifuged at 18,000 x g. The supernatant, containing the protein of interest, was saved while the
cell pellet was discarded. The protein of interest contained a histidine(His)-tag, which was captured
on a metal affinity chromatography resin. The TALON® cobalt resin contains sites with a high
affinity for His-tags and, therefore, allows purification of the protein from impurities. After
consecutive washings, the protein was eluted with elution buffer (50 mM Na2HP04,300 mM NaCI,
150 mM Imidazole). 1 mL fractions were collected.
SDS-polyacrylamide gel electrophoresis was used to characterize the first five elution
fractions as well as the supernatant, pellet, and flow-throughs obtained in the washing steps.
Results demonstrate that much of the protein was retained on the cobalt column even after
repeated washings. The protein was not found in the supernatant, pellet, or flow-throughs. At lower
incubation temperatures, the extent of expression was more pronounced.

Elution Fractions 37 °C

Elution Fractions 27 °C

VIII. Determining Functionality
Antibody binding was monitored in a noncompetitive enzyme-linked immunosorbent assay
(ELISA) using bovine serum albumin (BSA), p-azo-D-Phe-BSA, and p-azo-L-Phe-BSA as solid
phase coatings (100 mL/well; 1 mg/mL in 50 mM carbonate buffer, pH 9.6; 14 h at 4 °C).
Unoccupied adsorption sites were blocked with 1% gelatin in PBS/Tween (250 mL/well; 2 h at 37
°C). Fraction #3 (of 27 and 30 °C incubations) was diluted as follows: 1:1, 1:2, 1:5, 1:10, 1:20,
1:40. 50 mL- samples were added to each well and incubated for 2 h at 37 °C. Bound antibody
was detected with anti-His- or anti-mouse-horseradish peroxidase-conjugated antibodies. (1:5,000

Antibody binding to the immobilized antigen
was determined through a visible color change
resulting from the enzymatic conversion of ophenylendiamine (100 mL/well).
Using a spectrophotometer, the absorbance
of each sample was taken. Then the absorbance was
plotted against the concentration (see graphs in end pages).

ELISA RESULTS & DISCUSSION

Result noncompetitive ELISA results show that cells grown at 27 °C and 30 °C expressed
a functional 67.36 HIL scFv. At 27 °C, the protein binds to both p-azo-D-Phe-BSA and p-azo-LPhe-BSA, with a slight preference to the latter. At 30 °C a more pronounced preference is
observed. While these results suggest that the antibody 67.36 HIL scFv is stereoselective, it is
imperative that further tests, e.g., competitive ELISAs, are carried out to verify its enantiomeric
preference. A competitive ELISA, in which antibodies are allowed to bind to free antigen in solution,
is much more suited to unambiguously determine antibody specificity and stereoselectivity
In conclusion, we successfully ligated the light and heavy variable regions to create 67.36
HIL scFv. We were able to express 67.36 HIL scFV as a protein and found a temperature
dependence on the extent of expression. We determined that the expressed protein was functional.
Noncompetitive ELISA tests revealed that cells grown at 30 °C expressed protein with a
preference towards p-azo-L-Phe-BSA. In the future, competitive ELISA tests will be performed to
confirm the observed enantiomeric preference

Absorbance (492 nm)

GRAPH 1
67.36 HIL Binding Curve 27 °C

Dilution of fraction #3

Absorbance (492 nm)

GRAPH 2
67.36 HIL Binding Curve 27 °C
BSA values subtracted

Dilution of fraction #3

Absorbance (492 nm)

GRAPH 3
67.36 HIL Binding Curve 30 °C

Dilution of fraction #3

Absorbance (492 nm)

GRAPH 4
67.36 HIL Binding Curve 30 °C
BSA values subtracted

Dilution of fraction #3
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